Clinical Trials Directory

Trials / Conditions / Peritoneal Dialysis-associated Peritonitis

Peritoneal Dialysis-associated Peritonitis

17 registered clinical trials studyying Peritoneal Dialysis-associated Peritonitis2 currently recruiting.

StatusTrialSponsorPhase
RecruitingClinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis
NCT05971537
Alice Ho Miu Ling Nethersole HospitalPhase 4
RecruitingOral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
NCT05860270
Peking University First HospitalPhase 4
UnknownA Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal
NCT05285436
CloudCathN/A
CompletedNeutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) Clinical Trial Protocol
NCT05450523
Qingdao HIGHTOP Biotech Co., Ltd.
CompletedPharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Pat
NCT07113574
Karl Landsteiner Insitute for Nephrology and Haemato-OncologyPhase 2 / Phase 3
CompletedA Prospective Clinical Study of the CloudCath System During In-home Peritoneal Dialysis
NCT04515498
CloudCath
WithdrawnDefining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis
NCT03675854
Chinese University of Hong KongPhase 4
CompletedVancomycin Pharmacokinetics in Patients on Peritoneal Dialysis
NCT03685747
Thomas Jefferson UniversityPhase 1
SuspendedIn Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Devi
NCT05300191
CloudCath
CompletedThe Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
NCT03264625
Peking University First HospitalPhase 2
UnknownPeritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.
NCT03046511
Carmel Medical CenterPhase 3
CompletedComparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis
NCT02872038
Chulalongkorn UniversityPhase 4
CompletedPharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Auto
NCT07113587
Karl Landsteiner Insitute for Nephrology and Haemato-OncologyPhase 2 / Phase 3
CompletedBacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritoni
NCT01817309
Chinese University of Hong KongPhase 4
CompletedVancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-
NCT02787057
Peking University First HospitalN/A
CompletedPrevention of Peritonitis in Peritoneal Dialysis
NCT01293799
Sahlgrenska University HospitalN/A
TerminatedImproved Diagnosis of Peritoneal Dialysis Peritonitis by Calorimetry
NCT00801775
University Hospital, Basel, Switzerland